Feedback / Questions
LPX-TI641 - LAPIX Therap
https://www.globenewswire.com/news-release/2025/12/23/3209790/0/en/LAPIX-Therapeutics-Announces-First-Patient-Dosed-in-Phase-Ib-Study-of-LPX-TI641-in-Atopic-Dermatitis.html
Dec 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next